Zonula occludens toxin as a new promising adjuvant for mucosal vaccines

Vaccine

Volumn 24, Issue SUPPL. 2, 2006, Pages S60-S61

  Magistris, Maria Teresa De ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Bacterial toxins; Mucosal adjuvants; Vaccines

Indexed keywords

ENTEROTOXIN; UNCLASSIFIED DRUG; ZONULA OCCLUDENS TOXIN;

ANIMAL EXPERIMENT; ARTICLE; DRUG IDENTIFICATION; ESCHERICHIA COLI; IMMUNOGENICITY; INTESTINE MUCOSA PERMEABILITY; MOUSE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RECEPTOR BINDING; VIBRIO CHOLERAE;

EID: 33645223512     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.01.123     Document Type: Article

References (4)

1. F.W. van Ginkel, R.J. Jackson, Y. Yuki, and J.R. McGhee The mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues J Immunol 165 2000 4778 4782
2. M. Marinaro, A. Di Tommaso, S. Uzzau, A. Fasano, and M.T. De Magistris Zonula occludens toxin is a powerful mucosal adjuvant for intranasally delivered antigens Infect Immun 67 1999 1287 1291
3. M. Marinaro, A. Fasano, and M.T. De Magistris Zonula occludens toxin acts as an adjuvant through different mucosal routes and induces protective immune responses Infect Immun 71 2003 1897 1902
4. A. Fasano Regulation of intercellular tight junctions by Zonula occludens toxin and its eukaryotic analogue zonulin Ann NY Acad Sci 915 2000 214 222